Forkhead box O6 (FoxO6) promotes cardiac pathological remodeling and dysfunction by activating Kif15-TGF-β1 under aggravated afterload.
Forkhead box O6 (FoxO6) promotes cardiac pathological remodeling and dysfunction by activating Kif15-TGF-β1 under aggravated afterload.
复制标题
作者:
Zhang, Bing;Shi, Lei;Tan, Yanzhen;Zhou, Yenong;Cui, Jun;Song, Yujie;Liu, Yingying;Zhang, Miao;Duan, Weixun;Jin, Zhenxiao;Liu, Jincheng;Yi, Dinghua;Sun, Yang;Yi, Wei
Pathological cardiac hypertrophy exhibits complex and abnormal gene expression patterns and progresses to heart failure. Forkhead box protein O6 (FoxO6) is a key transcription factor involved in many biological processes. This study aimed to explore the role of FoxO6 in cardiac hypertrophy. Three groups of mice were established: wild‐type, FoxO6 knockout, and FoxO6‐overexpressing. The mice received daily administration of angiotensin‐II (Ang‐II) or saline for 4 weeks, after which they were examined for cardiac hypertrophy, fibrosis, and function. Elevated cardiac expression of FoxO6 was observed in Ang‐II‐treated mice. FoxO6 deficiency attenuated contractile dysfunction and cardiac remodeling, including cardiomyocyte hypertrophy and fibroblast proliferation and differentiation. Conversely, FoxO6 overexpression aggravated the cardiomyopathy and heart dysfunction. Further studies identified kinesin family member 15 (Kif15) as downstream molecule of FoxO6. Kif15 inhibition attenuated the aggravating effect of FoxO6 overexpression. In vitro, FoxO6 overexpression increased Kif15 expression in cardiomyocytes and elevated the concentration of transforming growth factor‐β1 (TGF‐β1) in the medium where fibroblasts were grown, exhibiting increased proliferation and differentiation, while FoxO6 knockdown attenuated this effect. Cardiac‐derived FoxO6 promoted pathological cardiac remodeling induced by aggravated afterload largely by activating the Kif15/TGF‐β1 axis. This result further complements the mechanisms of communication among different cells in the heart, providing novel therapeutic targets for heart failure. Pressure overload is a key promoter of hypertensive cardiac remodeling characterized by left ventricular hypertrophy and fibrosis. Cardiac fibrosis is characterized by abnormal gene expression patterns that can progress to heart failure and is identified as a vital therapeutic target for heart failure. The transcription factor FoxO6 is involved in many biological processes. The regulatory role of FoxO6 in cardiac diseases remains unclear. This study elucidated for the first time that. FoxO6 is an essential transcription factor that shows a strong association with the progression of cardiac disease. FoxO6 promotes pathological cardiac fibrosis and left ventricular contractile dysfunction by activating Kif15 and TGF‐β1 secretion in cardiomyocytes under pressure overload, which facilitates the proliferation and differentiation of fibroblasts. FoxO6 expression knockout leads to anti‐fibrosis effect and conserves cardiac function.
登录
查看更多内容
影响因子:
37.8
作者:
Park S;Ranjbarvaziri S;Lay FD;Zhao P;Miller MJ;Dhaliwal JS;Huertas-Vazquez A;Wu X;Qiao R;Soffer JM;Rau C;Wang Y;Mikkola HKA;Lusis AJ;Ardehali R
通讯作者:
Ardehali R
影响因子:
5
作者:
Lighthouse JK;Small EM
通讯作者:
Small EM
影响因子:
4
作者:
Chung SY;Huang WC;Su CW;Lee KW;Chi HC;Lin CT;Chen ST;Huang KM;Tsai MS;Yu HP;Chen SL
通讯作者:
Chen SL
影响因子:
8.3
作者:
Bragazzi, Nicola Luigi;Zhong, Wen;Dai, Haijiang
通讯作者:
Dai, Haijiang
影响因子:
20.1
作者:
Tachibana A;Santoso MR;Mahmoudi M;Shukla P;Wang L;Bennett M;Goldstone AB;Wang M;Fukushi M;Ebert AD;Woo YJ;Rulifson E;Yang PC
通讯作者:
Yang PC